Mozart Therapeutics
Vision
hange the treatment paradigm for patients with autoimmune and inflammatory diseases.
Approach
Mozart is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases. They aim to reset and restore the balance of the immune system by leveraging a novel pathway to develop first-in-class CD8 Treg modulators to delay onset, reduce severity and potentially reverse the course of disease that allow patients to lead normal lives.
Mozart Therapeutics is addressing
CEO:
Katie Fanning
Founders:
Mark M. Davis, PhD
K. Christopher Garcia, PhD
Calvin Kuo, MD, PhD
First investment:
April 2021